highly significantp < 0.01
The myocardial samples from the Simvastatin 40 group had importantly decreased incidence of cleaved caspase-3 positive muscle cells than those from the Simvastatin 20 group (20.6 ± 3.1% and 32.1 ± 5.8%, p < 0.05, respectively), and highly significant compared to the LPS group ( p < 0.01) (Fig. 3c–e ).